Corrigendum to "Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy" [Lung Cancer 69S1 (2010) S11-S18]

Giovanni Giuliani, Francesco Grossi, Filippo de Marinis, Stefan Walzer

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)118
Number of pages1
JournalLung Cancer
Volume71
Issue number1
DOIs
Publication statusPublished - Jan 2011

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this